Why the study?
Malignant extrarenal rhabdoid tumor is a rare, highly metastatic tumor associated with frequent misdiagnosis, delayed treatment, and high early mortality.
Malignant extrarenal rhabdoid tumor is a rare, highly metastatic tumor with a poor prognosis that requires prompt diagnosis and treatment.
Answers are grounded in this paper and cite their sources.
Fatal postoperative course in this rare tumor cautions against isolated surgery; leaves open optimal multimodal strategies.
BACKGROUND: Malignant extrarenal rhabdoid tumor (MERT) is a rare and highly metastatic tumor, which is more than 75% of patients dying within 6 months of initial diagnosis, and it often leads to misdiagnosis and delayed treatment. CASE: This paper reports a 16-year-old girl who presented with the chief complaint of acute abdominal pain. She underwent laparoscopic exploration and excisional biopsy, then pathological examination and immunohistochemistry revealed "extrarenal malignant rhabdomyoma." One month after operation, she died of intra-abdominal hemorrhage and multiple organ dysfunction. CONCLUSION: MERT were often misdiagnosed and had a poor prognosis. The surgery and chemotherapy are usually beneficial to prolong the survival time of patients with MERT.
No takes yet. Share an insight, caveat, or question.
Shao et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: